Immunogenic compositions for inhibiting hepatitis d virus
AssigneeChrontech Pharma AB
InventorsMatti Sällberg, Lars Frelin, Gustaf Ahlen
Life of this patent
Estimating the term…
Abstract
Disclosed herein are isolated nucleic acids, compositions of isolated nucleic acids, and compositions of polypeptides that are useful for the generation, enhancement, or improvement of an immune response to a target antigen. Some embodiments of the compositions include nucleic acids encoding hepatitis B core antigen (HBcAg) protein in combination with one or more self-cleavage 2A polypeptides and a second antigenic polypeptide. In certain embodiments, the HBcAg is as a stork or heron hepatitis antigen. In certain embodiments the self-cleavage polypeptide is P2A. In certain embodiments the second antigenic polypeptide of interest is NS5A, HDAg, or birch allergen.
Claims18
An isolated nucleic acid comprising a nucleic acid sequence that encodes a hepatitis D virus (HDV) polypeptide, HDAg-L or HDAg-S, wherein said nucleic acid is codon optimized for expression in humans.
2-37. (canceled)
Dependencies are inferred from the claim text.